Drug Reference
Metformin / Sitagliptin
Combinations of oral blood glucose lowering drugs
Fact box
- Therapeutic class
- Combinations of oral blood glucose lowering drugs
Brand names
JanumetZituvimet
Available as
1000 MG · Extended Release Oral Tablet500 MG · Extended Release Oral Tablet1000 MG · Oral Tablet500 MG · Oral Tablet
Multi-ingredient product
MetforminSitagliptin
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
- JANUMET (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS]
- SITAGLIPTIN AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED [APOTEX CORP.]
- SITAGLIPTIN AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED [SANDOZ INC]
- ZITUVIMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS USA INC.]
- ZITUVIMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ZYDUS LIFESCIENCES LIMITED]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.